U.S. flag

An official website of the United States government

Medicaid State Plan Amendments

A Medicaid and CHIP state plan is an agreement between a state and the Federal government describing how that state administers its Medicaid and CHIP programs. It gives an assurance that a state will abide by Federal rules and may claim Federal matching funds for its program activities. The state plan sets out groups of individuals to be covered, services to be provided, methodologies for providers to be reimbursed and the administrative activities that are underway in the state.

When a state is planning to make a change to its program policies or operational approach, states send state plan amendments (SPAs) to the Centers for Medicare & Medicaid Services (CMS) for review and approval. States also submit SPAs to request permissible program changes, make corrections, or update their Medicaid or CHIP state plan with new information.

Persons with disabilities having problems accessing the SPA PDF files may call 410-786-0429 for assistance.

Results

Displaying 3691 - 3700 of 15690

New York
To revise and enhance Assertive Community Treatment (ACT) services under the rehabilitative services benefit.
Approval Date: April 11, 2022
Effective Date: April 1, 2021

New York
To add pharmacy interns to Other Practitioner Services, under section Pharmacists and Pharmacy Interns as Immunizers. Also, this SPA proposes to reimburse for Diabetes Self-Management Training (DSMT) services for persons diagnosed with diabetes when such services are ordered by a physician, registered physician assistant, registered nurse practitioner, or licensed midwife and provided by a licensed, registered, or certified health care professional.
Approval Date: April 11, 2022
Effective Date: July 1, 2021

Rhode Island
Mandatory coverage of routine patient costs for services furnished in connection with qualifying clinical trials.
Approval Date: April 8, 2022
Effective Date: January 1, 2022

North Carolina
This amendment complies with Section 210 of the Consolidated Appropriations Act of 2021 by adding a new mandatory benefit of routine patient services and costs furnished in connection with participation by Medicaid beneficiaries in qualifying clinical trials.
 
Approval Date: April 8, 2022
Effective Date: January 1, 2022

Arkansas
CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency.  The purpose of this amendment is to waive signature requirements related to dispensing of drugs during the COVID-19 public health emergency.
Approval Date: April 8, 2022
Effective Date: March 13, 2020
Topics: Disaster Relief Prescription Drugs

Alabama
This amendment is regarding clinical trials and is in compliance with SMD # 21-005, as it relates to the Consolidated Appropriations Act, 2021 (Public Law 116-260).
Approval Date: April 7, 2022
Effective Date: January 1, 2022

Virginia
This amendment proposes to add coverage for Virginia’s Clinical Trials.
Approval Date: April 7, 2022
Effective Date: January 1, 2022

Pennsylvania
This State Plan Amendment provides required assurances that the state is appropriately covering and paying for routine patient costs of items and services for beneficiaries enrolled in qualifying clinical trials.
Approval Date: April 7, 2022
Effective Date: January 1, 2022

New Jersey
The state proposes to include an assurance that the state covers routine patient costs for items and services furnished in connection with participation by Medicaid beneficiaries in qualifying clinical trials.
Approval Date: April 7, 2022
Effective Date: January 1, 2022

Arkansas
Vagus Nerve Stimulation Therapy
Approval Date: April 6, 2022
Effective Date: No Effective Date
Topics: Financing & Reimbursement